Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging

Citation
M. Hutchinson et U. Raff, Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging, AM J NEUROR, 21(4), 2000, pp. 697-701
Citations number
20
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Neurosciences & Behavoir
Journal title
AMERICAN JOURNAL OF NEURORADIOLOGY
ISSN journal
01956108 → ACNP
Volume
21
Issue
4
Year of publication
2000
Pages
697 - 701
Database
ISI
SICI code
0195-6108(200004)21:4<697:SCOTSN>2.0.ZU;2-7
Abstract
BACKGROUND AND PURPOSE: The possibility of using MR imaging as a sensitive marker of the structural changes in Parkinson's disease has been a long-sou ght goal. We describe a new method for imaging and quantifying the morpholo gic changes of the substantia nigra in Parkinson's disease and compare radi ologic findings with clinical evaluation. METHODS: Using a combination of two MR imaging inversion-recovery pulse seq uences, the substantia nigra was imaged in six patients with Parkinson's di sease and six age-related control participants. A radiologic index was defi ned and used to quantify the signal changes that were observed in the patie nts. The radiologic index was compared with clinical scores obtained from t he Unified Parkinson's Disease Rating Scale. RESULTS: The images showed loss of signal in a lateral-to-medial gradient i n cases of Parkinson's disease, corresponding to the known neuropathologic pattern of degeneration. The radiologic index was highly correlated with th e Unified Parkinson's Disease Rating Scale score, and there was no overlap in radiologic indices between the patient and the control groups (P < .0000 5), CONCLUSION: This study suggests that MR imaging is sensitive to structural changes in even the earliest cases of Parkinson's disease, thereby indicati ng the potential for detecting presymptomatic disease. Furthermore, a radio logic measure has been defined that correlates with the conventional clinic al measure of disease severity. Therefore, MR imaging could prove to be a s ensitive biological marker for objective staging of the disease.